Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

620
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
620
Infertility in Males01:23

Infertility in Males

259
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
259
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

386
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
386
Menopause01:28

Menopause

154
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
154
Signs of Puberty01:27

Signs of Puberty

318
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
318
Testes: Gross Anatomy01:19

Testes: Gross Anatomy

1.9K
The testes, also known as testicles, are the male gonads. They are housed within the scrotum, a sac-like structure located beneath the penis. The scrotum's primary role is to regulate the temperature of the testes, which is crucial for sperm production.
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

We Care, and We Will Listen.

Primary care·2026
Same author

A Blueprint for Public Health.

Primary care·2026
Same author

An Emerging Issue in Journal Publishing: The Use of Artificial Intelligence to Generate Letters to the Editor.

PRiMER (Leawood, Kan.)·2026
Same author

Reviewer Engagement Trends at a Journal: Cause for Concern.

PRiMER (Leawood, Kan.)·2026
Same author

Doctors versus Computers.

Primary care·2025
Same author

Best Practices for Advising Students for the NRMP Match in Family Medicine.

PRiMER (Leawood, Kan.)·2025

Related Experiment Video

Updated: Jun 23, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

716

Testosterone Replacement Therapy for Male Hypogonadism.

Joel J Heidelbaugh1, Aleksandr Belakovskiy1

  • 1University of Michigan Medical School, Ann Arbor, Michigan.

American Family Physician
|June 21, 2024
PubMed
Summary

Testosterone replacement therapy can improve hypogonadism symptoms like low bone density and lean mass. Recent trials indicate it does not raise cardiovascular risks, supporting its consideration for eligible men.

Area of Science:

  • Endocrinology
  • Men's Health
  • Clinical Medicine

Background:

  • Testosterone deficiency (hypogonadism) is defined by low serum testosterone and related symptoms.
  • Potential benefits of testosterone replacement therapy (TRT) include improved sexual function, mood, bone density, and lean body mass.
  • Conflicting evidence exists regarding TRT's impact on cardiovascular events and mortality.

Purpose of the Study:

  • To review the current understanding of testosterone deficiency and its management.
  • To evaluate the benefits and risks of testosterone replacement therapy, particularly cardiovascular safety.
  • To provide guidance on initiating and monitoring TRT in eligible men.

Main Methods:

  • Review of existing studies and a large, randomized trial on testosterone replacement therapy.

More Related Videos

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

45.6K
Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
07:37

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Published on: August 16, 2024

1.2K

Related Experiment Videos

Last Updated: Jun 23, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

716
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

45.6K
Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
07:37

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Published on: August 16, 2024

1.2K
  • Analysis of evidence concerning TRT's effects on sexual function, mood, body composition, and cardiovascular outcomes.
  • Consideration of patient-centered factors for treatment selection and monitoring protocols.
  • Main Results:

    • TRT may improve sexual function, depressive symptoms, bone density, and lean body mass.
    • A major randomized trial demonstrated no increased risk of myocardial infarction or stroke with TRT, even in high-risk patients.
    • Prior concerns about increased cardiovascular risk with TRT are not supported by recent large-scale evidence.

    Conclusions:

    • Testosterone replacement therapy should be considered for men with testosterone deficiency after shared decision-making regarding benefits and risks.
    • Treatment selection requires consideration of patient preferences, pharmacokinetics, adverse effects, and cost.
    • Regular monitoring of symptoms, adverse effects, adherence, and specific lab parameters (testosterone, hematocrit, PSA) is crucial for men on TRT.